Function is a company that focuses on treating cancer through personalized approaches. Function analyzes patients' cells to develop tailored treatment strategies.

Function

Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform to understand cancer in unprecedented and patient-specific detail. By moving beyond traditional gene sequencing to measuring gene function, Function Oncology aims to identify optimal therapeutic opportunities for patients and advance the next generation of targeted cancer therapies.

This Monday, April 8th, members of our team are excited to be at the American Association for Cancer Research’s Annual Meeting 2024 in San Diego. At Function, our platform leverages #CRISPR technology to understand cancer in unprecedented and patient-specific detail. For a full list of posters and presentations, click the link here: https://lnkd.in/g6P3g2CD #AACR24

We’re incredibly excited to partner with the  Volastra Therapeutics team to accelerate the clinical impact of their KIF18A inhibitors! Just one example of how CRISPR-based precision medicine can positively impact lives by putting patients at the center of drug development.

We are thrilled to announce our partnership with Volastra Therapeutics, bringing together our CRISPR-enabled personalized functional genomics technology with Volastra’s expertise in chromosomal instability to expand patient selection for Volastra’s KIF18A inhibitors. This partnership marks the first of many as we seek to create breakthrough treatments for those struggling with life threatening illnesses. Hear more on the partnership from our co-founder and CEO Srinath Sampath MD PhD and Volastra Head of R&D and CMO Scott Drutman  MD PhD in the video below and read the press release here: https://lnkd.in/dyDGZ97c

At Function, we’re not playing Tetris, but we are fitting pieces together. Our #CRISPR-powered personalized functional genomics platform and unparalleled expertise come together to take #precisionmedicine to the next level. We hope you’ll follow along as the pieces fall into place: https://lnkd.in/eTgwH97y

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 2, 2024 12:28 AM	c3ee43a1
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Sep 2, 2024 11:28 PM	7678bdd3
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Sep 2, 2024 12:28 AM	91bffc37
translate crunchbase fundingrounds	general
peers	general	Sep 2, 2024 12:28 AM	70c8ba8d
news basic	general	Sep 2, 2024 12:28 AM	408abd7a
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:FUNCTIONONCOLOGY

Function